Does ELOTUZUMAB Cause Embolism? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Embolism have been filed in association with ELOTUZUMAB (EMPLICITI). This represents 0.3% of all adverse event reports for ELOTUZUMAB.
10
Reports of Embolism with ELOTUZUMAB
0.3%
of all ELOTUZUMAB reports
5
Deaths
3
Hospitalizations
How Dangerous Is Embolism From ELOTUZUMAB?
Of the 10 reports, 5 (50.0%) resulted in death, 3 (30.0%) required hospitalization.
Is Embolism Listed in the Official Label?
Yes, Embolism is listed as a known adverse reaction in the official FDA drug label for ELOTUZUMAB.
What Other Side Effects Does ELOTUZUMAB Cause?
Plasma cell myeloma (339)
Death (234)
Malignant neoplasm progression (227)
Pneumonia (209)
Pyrexia (183)
Drug ineffective (137)
Neutropenia (133)
Anaemia (119)
Thrombocytopenia (107)
Diarrhoea (105)
What Other Drugs Cause Embolism?
BEVACIZUMAB (378)
PACLITAXEL (251)
LENALIDOMIDE (206)
DEXAMETHASONE (204)
RITUXIMAB (204)
CYCLOPHOSPHAMIDE (202)
DOXORUBICIN (198)
RIVAROXABAN (197)
CARBOPLATIN (187)
APIXABAN (181)
Which ELOTUZUMAB Alternatives Have Lower Embolism Risk?
ELOTUZUMAB vs ELOXATIN
ELOTUZUMAB vs ELRANATAMAB
ELOTUZUMAB vs ELRANATAMAB-BCMM
ELOTUZUMAB vs ELTROMBOPAG
ELOTUZUMAB vs ELTROMBOPAG OLAMINE